Multicentric evaluation of two chemiluminescent immunoassays for IgG and IgM antibodies towards Rubella virus

Journal of Clinical Virology

Volumn 49, Issue 2, 2010, Pages 105-110

  Portella, Giuseppe ^a   Galli, Claudio ^b  

^a FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^b ABBOTT DIAGNOSTICS   (Italy)

Author keywords

IgG; IgM; Pregnancy; Rubella virus; Seroprevalence; Vaccination

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; ITALY; LABORATORY; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; QUALITATIVE DIAGNOSIS; RUBELLA VIRUS; SENSITIVITY AND SPECIFICITY; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; AUTOMATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREGNANCY; RUBELLA; RUBELLA VIRUS; VIROLOGY; YOUNG ADULT;

EID: 77956649023     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.07.011     Document Type: Article

References (21)

1. Louie J.K., Shaikh-Laskos R., Preas C., Nguyen V.Y., Peters A., Messenger S. Re-emergence of another vaccine-preventable disease?-two cases of Rubella in older adults. J Clin Virol 2009, 46:98-100.
2. Nardone A., Tischer A., Andrews N., Backhouse J., Theeten H., Gatcheva N., et al. Comparison of Rubella seroepidemiology in 17 countries: progress towards international disease control targets. Bull WHO 2008, 86:118-125.
3. Robinson J.L., Lee B.E., Preiksaitis J.K., Plitt S., Tipples G.A. Prevention of Congenital Rubella Syndrome-what makes sense in 2006?. Epidemiol Rev 2006, 28:81-87.
4. Reef S.E., Plotkin S., Cordero J.F., Katz M., Cooper L., Schwartz B., et al. Preparing for elimination of Congenital Rubella Syndrome (CRS): summary of a workshop on CRS elimination in the United States. Clin Infect Dis 2000, 31:85-95.
5. Banatvala J.E., Brown D.W. Rubella. Lancet 2004, 363:1127-1137.
6. Rota M.C., Bella A., Gabutti G., Giambi C., Filia A., Guido M., et al. Rubella seroprofile of the Italian population: an 8-year comparison. Epidemiol Infect 2007, 135:555-562.
7. Bonanni P., Bechini A., Boccalini S., Peruzzi M., Tiscione E., Boncompagni G., et al. Progress in Italy in control and elimination of measles and congenital rubella. Vaccine 2007, 25:3105-3110.
8. Giambi C., Rota M.C., Bella A., Filia A., Gabutti G., Guido M., et al. Rubella epidemiology in Italy in years 1998-2004. Ann Ig 2007, 19:93-102.
9. Shukla D., Ramachandran V.G., Arora R. Cytomegalovirus and Rubella infection in children and pregnant mothers-a hospital based survey. J Commun Dis 2007, 39:113-117.
10. Hyde T.B., Kruszon-Moran D., McQuillan G.M., Cossen C., Forghani B., Reef S.E. Rubella immunity levels in the United States population: has the threshold of viral elimination been reached?. Clin Infect Dis 2006, 43:S146-S150.
11. Goncalves G., Sao Josè Nascimento M., Reu C., Cutts F.T. Levels of Rubella antibody among vaccinated and unvaccinated Portuguese women and their newborns. Vaccine 2006, 24:7142-7147.
12. Vauloup-Fellous C., Grangeot-Keros L. Humoral immune response after primary Rubella virus infection and after vaccination. Clin Vacc Immunol 2007, 14:644-647.
13. Davidkin I., Jokinen S., Broman M., Leinikki P., Petola H. Persistence of Measles, Mumps and Rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis 2008, 197:950-956.
14. LeBaron C.W., Forghani B., Matter L., Reef S.E., Beck C., Bi D., et al. Persistence of Rubella antibodies after 2 doses of Measles-Mumps-Rubella vaccine. J Infect Dis 2009, 200:888-899.
15. Amanna I.J., Carlson M.E., Slifka M.K. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007, 357:1903-1915.
16. Tipples G.A., Hamkar R., Mohktari-Azad T., Gray M., Ball J., Head C., et al. Evaluation of Rubella IgM enzyme immunoassays. J Clin Virol 2004, 30:233-238.
17. Medici M.C., Martinelli M., Albonetti V., Chezzi C., Dettori G. Evaluation of Rubella virus immunoglobulin G (IgG) and IgM assays with the new Vidia instrument. J Clin Microbiol 2008, 46:1847-1849.
18. Dimech W., Panagiotopoulos L., Francis B., Laven N., Marler J., Dickeson D., et al. Evaluation of eight anti-Rubella virus immunoglobulin G immunoassays that report results in international units per millilitre. J Clin Microbiol 2008, 46:1955-1960.
19. Eichler R., Prostko J., Fischer C., Hausmann M., Christ H. Evaluation of the new ARCHITECT Rubella IgM immunoassay. J Clin Virol 2007, 39:182-187.
20. Oliveira L.C., Kawasato K.H., Lima L.P., Okay T.S. Comparison of two commercial immunoassays for the detection of anti-Rubella IgM and IgG in pediatric patients. J Immunoass Immunochem 2007, 28:297-306.
21. Trevisan A., Frasson C., Morandin M., Beggio M., Bruno A., Davanzo E., et al. Immunity against infectious diseases: predictive value of self-reported history of vaccination and disease. Infect Control Hosp Epidemiol 2007, 28:564-569.